drugset / Trial / NCT00664287
Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test the effect of MK0524A (niacin (+) laropiprant) on lowering bad cholesterol and raising good cholesterol.
Timeline
- Start
- 2008-09
- Primary completion
- 2009-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niacin | Small molecule | 2 g | — |
| Subject | laropiprant | Small molecule | 40 mg | — |